ZYBT · Zhengye Biotechnology Holding Ltd

$1.16 -0.08 (-6.10%)

Market Cap

$54.26M

47.39M

Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.

Revenue

116.36M -37.6%

FY2025

Net Income

-69.78M -717%

FY2025

Diluted EPS

0.25

FY2024

Operating Cash Flow

13.33M -67.5%

FY2025

Chart any reported metric, KPI or segment over time — the full statement history lives here

Income Statement Balance Sheet Cash Flow All Metrics

Annual Quarterly

Line Item	FY2025	FY2024
Revenue CNY	116.36M	186.36M
Cost of Revenue CNY	92.49M	95.06M
Gross Profit CNY	23.87M	91.3M
Research & Development CNY	18.01M	12.79M
Selling & Marketing CNY	43.92M	41.27M
General & Administrative CNY	31.01M	22.58M
Amortization of Intangibles CNY	4.41M	3.45M
Depreciation & Amortization CNY	25.88M	24.16M
Total Operating Expenses CNY	94.38M	74.86M
Operating Income CNY	-70.51M	16.44M
Interest Expense CNY	3.4M	4.04M
Interest Income CNY	96K	231K
Other Non-Operating Income CNY	-1.37M	-2.05M
Pretax Income CNY	-71.87M	14.39M
Income Tax CNY	11.1M	924K
Net Income CNY	-69.78M	11.31M
Net Income Attributable to Noncontrolling Interests CNY	-13.18M	2.16M
Comprehensive Income CNY	-71.71M	11.31M
EPS (Basic) CNY/shares	—	0.25
EPS (Diluted) CNY/shares	—	0.25
Shares Outstanding (Basic Avg) shares	47.35M	45.67M
Shares Outstanding (Diluted Avg) shares	47.35M	45.67M

Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.

Capital Returned to Shareholders

Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2024–FY2025: $32.05M in dividends.

Revenue Breakdown

Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.

Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.

By Product & Service (CNY)

Component	FY2025	FY2024	FY2023	FY2022
Distribution Network	61,501,000	59,854,000	49,623,000	47,845,000
Direct Sales Channel	51,897,000	121,774,000	159,529,000	207,324,000
Government Tender and Procurement	2,964,000	4,728,000	2,499,000	5,100,000

Key facts CIK 1975641 CUSIP G989MS101 Visit website Investor relations